Study: NCT03519854

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sugammadex
Description: Sugammadex administered as a fast IV bolus dose (within 30 seconds), dosed according to participant actual body weight.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sugammadex
Description: Sugammadex administered as a fast IV bolus dose (within 30 seconds), dosed according to participant actual body weight.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sugammadex
Description: Sugammadex administered as a fast IV bolus dose (within 30 seconds), dosed according to participant actual body weight.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sugammadex
Description: Sugammadex administered as a fast IV bolus dose (within 30 seconds), dosed according to participant actual body weight.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sugammadex
Description: Sugammadex administered as a fast IV bolus dose (within 30 seconds), dosed according to participant actual body weight.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sugammadex
Description: Sugammadex administered as a fast IV bolus dose (within 30 seconds), dosed according to participant actual body weight.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sugammadex
Description: Sugammadex administered as a fast IV bolus dose (within 30 seconds), dosed according to participant actual body weight.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sugammadex
Description: Sugammadex administered as a fast IV bolus dose (within 30 seconds), dosed according to participant actual body weight.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sugammadex
Description: Sugammadex administered as a fast IV bolus dose (within 30 seconds), dosed according to participant actual body weight.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sugammadex
Description: Sugammadex administered as a fast IV bolus dose (within 30 seconds), dosed according to participant actual body weight.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sugammadex
Description: Sugammadex administered as a fast IV bolus dose (within 30 seconds), dosed according to participant actual body weight.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sugammadex
Description: Sugammadex administered as a fast IV bolus dose (within 30 seconds), dosed according to participant actual body weight.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sugammadex
Description: Sugammadex administered as a fast IV bolus dose (within 30 seconds), dosed according to participant actual body weight.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sugammadex
Description: Sugammadex administered as a fast IV bolus dose (within 30 seconds), dosed according to participant actual body weight.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sugammadex
Description: Sugammadex administered as a fast IV bolus dose (within 30 seconds), dosed according to participant actual body weight.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Esmeron®
Description: Esmeron® administered at 0.6 mg/kg as a fast IV bolus (within 10 seconds), dosed according to participant actual body weight.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Esmeron®
Description: Esmeron® administered at 0.6 mg/kg as a fast IV bolus (within 10 seconds), dosed according to participant actual body weight.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Esmeron®
Description: Esmeron® administered at 0.6 mg/kg as a fast IV bolus (within 10 seconds), dosed according to participant actual body weight.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Esmeron®
Description: Esmeron® administered at 0.6 mg/kg as a fast IV bolus (within 10 seconds), dosed according to participant actual body weight.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Esmeron®
Description: Esmeron® administered at 0.6 mg/kg as a fast IV bolus (within 10 seconds), dosed according to participant actual body weight.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Esmeron®
Description: Esmeron® administered at 0.6 mg/kg as a fast IV bolus (within 10 seconds), dosed according to participant actual body weight.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Esmeron®
Description: Esmeron® administered at 0.6 mg/kg as a fast IV bolus (within 10 seconds), dosed according to participant actual body weight.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Esmeron®
Description: Esmeron® administered at 0.6 mg/kg as a fast IV bolus (within 10 seconds), dosed according to participant actual body weight.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Esmeron®
Description: Esmeron® administered at 0.6 mg/kg as a fast IV bolus (within 10 seconds), dosed according to participant actual body weight.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Esmeron®
Description: Esmeron® administered at 0.6 mg/kg as a fast IV bolus (within 10 seconds), dosed according to participant actual body weight.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Esmeron®
Description: Esmeron® administered at 0.6 mg/kg as a fast IV bolus (within 10 seconds), dosed according to participant actual body weight.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Esmeron®
Description: Esmeron® administered at 0.6 mg/kg as a fast IV bolus (within 10 seconds), dosed according to participant actual body weight.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Esmeron®
Description: Esmeron® administered at 0.6 mg/kg as a fast IV bolus (within 10 seconds), dosed according to participant actual body weight.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Esmeron®
Description: Esmeron® administered at 0.6 mg/kg as a fast IV bolus (within 10 seconds), dosed according to participant actual body weight.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Esmeron®
Description: Esmeron® administered at 0.6 mg/kg as a fast IV bolus (within 10 seconds), dosed according to participant actual body weight.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Esmeron®
Description: Esmeron® administered at 0.6 mg/kg as a fast IV bolus (within 10 seconds), dosed according to participant actual body weight.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Esmeron®
Description: Esmeron® administered at 0.6 mg/kg as a fast IV bolus (within 10 seconds), dosed according to participant actual body weight.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Esmeron®
Description: Esmeron® administered at 0.6 mg/kg as a fast IV bolus (within 10 seconds), dosed according to participant actual body weight.